Post Image

ED & Endothelial Dysfunction


Endothelium-specific gene and stem cell-based therapy for erectile dysfunction.
Strong TD, Gebska MA, Burnett AL, Champion HC, Bivalacqua TJ.
Abstract
Erectile dysfunction (ED) commonly results from endothelial dysfunction of the systemic vasculature. Although phosphodiesterase type 5 (PDE-5) inhibitors are effective at treating most cases of ED, they must be taken routinely and are ineffectual for a meaningful number of men. In recent years gene and stem cell-based therapies targeted at the penile endothelium have been gaining momentum in preclinical studies. These early studies reveal that gene and stem cell-based therapies may be both enduring and efficacious, and may eventually lead to a cure for ED. The following review will highlight our current understanding of endothelial-specific gene and stem cell-based therapies performed to date in a number of experimental animal models.
PMID: 18087639 [PubMed – indexed for MEDLINE]

Contact Us

Have questions about Stem Cell Therapy?
Fill out the form or contact us below and we’ll be in touch!

Join the Revolution

Learn how to take your practice to the next level. Set up a consultation below

    Cell Surgical Network is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account. From time to time, we would like to contact you about conference details and special pricing, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please check the box below.

    You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy. By clicking submit below, you consent to allow Cell Surgical Network to store and process the personal information submitted above to provide you the content requested.